Pressure Bio Stock Price, News & Analysis
Company Description
Pressure Bio (OTC Link: PBIO) is a publicly traded medical devices company in the Healthcare sector. The company has a market capitalization of $4.1K.
PBIO stock has declined 97.8% over the past year. Shares last traded at $0.0001.
This page provides a comprehensive overview of PBIO stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Pressure Bio (PBIO) stock last traded at $0.0001, down 80.00% from the previous close. Over the past 12 months, the stock has lost 97.8%. At a market capitalization of $4.1K, PBIO is classified as a micro-cap stock with approximately 41.0M shares outstanding.
Latest News
Pressure Bio has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include partnership, conferences, acquisition. View all PBIO news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Pressure Bio (PBIO) currently stands at 13 shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Pressure Bio (PBIO) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
PBIO Company Profile & Sector Positioning
Pressure Bio (PBIO) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing PBIO often look at related companies in the same sector, including Nemaura Med Inc (NMRD), TRANSLATE BIO, INC. (TBIO), Opgen (OPGN), Motus Gi Hldgs Inc (MOTS), and Guided Thera (GTHP). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate PBIO's relative position within its industry.